As the first collision industry information provider to sign a data licensing agreement with Rivian, Mitchell is proud to be a Platinum Sponsor of the 2024 Certified Collision Network Summit. The Mitchell team will be on-hand to demonstrate how repair shops can leverage Mitchell’s cloud-based estimating and Mitchell Cloud Estimating TruckMax to access OEM repair information for Rivian vehicles. With an abundance of presentations and networking opportunities, this event will help attendees enhance their knowledge of Rivian vehicles and the tools and technology used to repair them.
More stories
Mitchell Expands Its Intelligent Open Platform and Support for AI-Enabled Vehicle Inspections Through Collaboration With PAVE
September 9, 2024
Mitchell today announced that it is teaming up with PAVE to automate vehicle inspections and conditioning. Using Mitchell’s cloud-based appraisal solution, comprehensive data and open platform with PAVE’s proprietary artificial intelligence (AI) and guided image capture application, U.S. and Canadian organizations will be able to generate graded condition reports from uploaded photos.
Battery Electric Vehicle Collision Claims Continue to Rise Despite Sales Slowdown
August 15, 2024
Mitchell today published its Q2 2024 Plugged-In: EV Collision Insights report. This edition features the latest U.S. and Canadian claims data on battery electric vehicles (BEVs), mild hybrid electric vehicles (MHEVs) and plug-in hybrid electric vehicles (PHEVs)—highlighting how differences in their complexity and construction are affecting claim costs and repair operations.
Plugged-In: EV Collision Insights Q2 2024
August 15, 2024
Claims frequency for repairable, collision-damaged battery electric vehicles (BEVs) rose to 2.5% in the U.S. and 3.94% in Canada in Q2 2024—a year-over-year increase of 45% and 39% respectively. According to the Alliance for Automotive Innovation, EVs represented 9.3% of new U.S. light-duty vehicle sales in Q1 2024, down from 10.2% in Q4 2023. Similarly, in Canada BEV sales fell to 9.2% last quarter, down from 10% in Q4 2023.
Bridging the Gap for New Adjusters with Innovative Tools
August 13, 2024
Streamline your claims process and support your team with our cutting-edge solutions.
SEMA 2024
The SEMA Show is the premier destination for manufacturers and buyers looking to discover thousands of the latest innovations in the automotive aft
New Trends in Opioids and Pain Management
August 7, 2024
Despite decreases in utilization and cost per claim, opioids remain the No. 1 drug class in Enlyte’s 2024 Drug Trends Report. However, due to concerns with safety and overutilization, increased focus on usage guidelines as well as alternatives to pain management are gaining momentum — including those whose active ingredients drive from things you might not imagine, like pufferfish, cacti and chili peppers. Enlyte’s Nikki Wilson explores this and more in our Part 3 drug trends analysis.